On Dec 22, 2021, the US Food and Drug Administration (FDA) issued an emergency use authorisation for Pfizer's COVID-19 antiviral, Paxlovid. Trial results released by the manufacturer indicate that the drug cuts the risk of hospitalisation or death for ...
source https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(22)00011-X/fulltext
No comments:
Post a Comment
We're away Reply You ASAP!